357 related articles for article (PubMed ID: 31858844)
1. Synergistic effect of rituximab with anti-epileptic drugs in treating sero-negative limbic encephalitis: a case report.
Xu Y
Int J Neurosci; 2020 Aug; 130(8):852-855. PubMed ID: 31858844
[No Abstract] [Full Text] [Related]
2. Efficacy of rituximab on seizure control and cognitive symptoms in leucine-rich, glioma-inactivated 1 (LGI1) limbic encephalitis: a high-density electroencephalography case study.
Cheli M; Dinoto A; Tommasini V; Ajčević M; Stella G; Catalan M; Stokelj D; Sartori A; Manganotti P
Epileptic Disord; 2020 Oct; 22(5):678-682. PubMed ID: 33146142
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for Refractory Autoimmune Encephalitis.
Yang J; Liu X
Front Immunol; 2021; 12():790962. PubMed ID: 34975890
[TBL] [Abstract][Full Text] [Related]
4. Limbic encephalitis in Taiwanese children and adolescence: a single center study.
Chou IJ; Wang HS; Lin JJ; Kuo CF; Lin KL; Chou ML; Hung PC; Hsieh MY; Lin YT;
Pediatr Neonatol; 2013 Aug; 54(4):246-53. PubMed ID: 23597520
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor.
Kung DH; Qiu C; Kass JS
Psychosomatics; 2011; 52(1):82-5. PubMed ID: 21300200
[No Abstract] [Full Text] [Related]
6. Sexual behaviour change in seronegative limbic encephalitis due to the involvement of the left amygdala.
Varoglu AO; Karatepe HT
J Pak Med Assoc; 2022 Aug; 72(8):1656-1658. PubMed ID: 36280940
[TBL] [Abstract][Full Text] [Related]
7. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis.
Wong SH; Saunders MD; Larner AJ; Das K; Hart IK
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1167-9. PubMed ID: 20660916
[TBL] [Abstract][Full Text] [Related]
8. Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
Li TR; Zhang YD; Wang Q; Shao XQ; Li ZM; Lv RJ
BMC Neurosci; 2020 Mar; 21(1):13. PubMed ID: 32228575
[TBL] [Abstract][Full Text] [Related]
9. A case of bilateral limbic and recurrent unilateral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody positivity.
Horita T; Inoue T; Kuki I; Nagase S; Yamamoto N; Yamada N; Oki K; Nukui M; Okazaki S; Amo K; Kawawaki H; Sakuma H; Togawa M
Brain Dev; 2022 Mar; 44(3):254-258. PubMed ID: 34802814
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of multimodality treatment for autoimmune limbic epilepsy.
Dubey D; Konikkara J; Modur PN; Agostini M; Gupta P; Shu F; Vernino S
Epileptic Disord; 2014 Dec; 16(4):494-9. PubMed ID: 25465439
[TBL] [Abstract][Full Text] [Related]
11. Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis.
Mazzi G; Roia DD; Cruciatti B; Matà S; Catapano R
Transfus Apher Sci; 2008 Dec; 39(3):229-33. PubMed ID: 18955013
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
[TBL] [Abstract][Full Text] [Related]
13. Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier.
Hainsworth JB; Shishido A; Theeler BJ; Carroll CG; Fasano RE
Epileptic Disord; 2014 Dec; 16(4):486-93. PubMed ID: 25465280
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study.
Sabanathan S; Abdel-Mannan O; Mankad K; Siddiqui A; Das K; Carr L; Eltze C; Eyre M; Gadian J; Hemingway C; Kaliakatsos M; Kneen R; Krishnakumar D; Lynch B; Parida A; Rossor T; Taylor M; Wassmer E; Wright S; Lim M; Hacohen Y
Ann Clin Transl Neurol; 2022 Jan; 9(1):67-78. PubMed ID: 35015932
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies.
Modoni A; Masciullo M; Spinelli P; Marra C; Tartaglione T; Andreetta F; Tonali P; Silvestri G
Cogn Behav Neurol; 2009 Mar; 22(1):63-6. PubMed ID: 19372772
[TBL] [Abstract][Full Text] [Related]
16. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Cavaletti G; Giannini F; Sabatelli M; Beghi E;
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):729-34. PubMed ID: 25246645
[TBL] [Abstract][Full Text] [Related]
17. Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases.
Mishra N; Rodan LH; Nita DA; Gresa-Arribas N; Kobayashi J; Benseler SM
J Child Neurol; 2014 May; 29(5):677-83. PubMed ID: 24092895
[TBL] [Abstract][Full Text] [Related]
18. Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures.
Cash SS; Larvie M; Dalmau J
N Engl J Med; 2011 Nov; 365(19):1825-33. PubMed ID: 22070480
[No Abstract] [Full Text] [Related]
19. Three case studies of nonparaneoplastic limbic encephalitis (NPLE) in young adult males: Onset, course, and recovery following rehabilitation services.
Perna R; Harik L; Arenivas A
Appl Neuropsychol Child; 2019; 8(1):93-99. PubMed ID: 29185868
[TBL] [Abstract][Full Text] [Related]
20. Gamma-aminobutyric acid-B limbic encephalitis and asystolic cardiac arrest: a case report.
Ovens CA; Jayamanne A; Duggins A
J Med Case Rep; 2017 Dec; 11(1):361. PubMed ID: 29287596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
